2022
Correction to: Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty
Gianakos A, Saad B, Haring R, Menken L, Elkattaway S, Liporace F, Yoon R. Correction to: Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty. Patient Safety In Surgery 2022, 16: 1. PMID: 34996502, PMCID: PMC8742330, DOI: 10.1186/s13037-021-00313-6.Peer-Reviewed Original Research
2019
Benign Pediatric Tumors and Tumor-Like Conditions of the Hip
Miller J, Patel J, Gianakos A, Hoskins T, Goyette D, Wittig J. Benign Pediatric Tumors and Tumor-Like Conditions of the Hip. The Journal Of Hip Surgery 2019, 03: 026-033. DOI: 10.1055/s-0039-1679940.Peer-Reviewed Original ResearchBenign Bone Tumors about the Hip
Patel J, Gianakos A, Miller J, Hoskins T, Wittig J. Benign Bone Tumors about the Hip. The Journal Of Hip Surgery 2019, 03: 008-013. DOI: 10.1055/s-0039-1678741.Peer-Reviewed Original ResearchOverview of Primary Malignant Tumors Affecting the Hip
Gianakos A, Patel J, Miller J, Wittig J. Overview of Primary Malignant Tumors Affecting the Hip. The Journal Of Hip Surgery 2019, 03: 019-025. DOI: 10.1055/s-0039-1678742.Peer-Reviewed Original ResearchHip jointPrimary malignant tumorsSenior author’s preferred techniqueMalignant disease processesPreferred techniqueAuthors' preferred techniqueNonspecific symptomsEndoprosthetic reconstructionMalignant diseasePatient outcomesMalignant tumorsDisease processProper diagnosisJoint stiffnessPainMalignancyJointsSymptomsTumorsHipDiseaseDiagnosisMetastatic Disease, Myeloma, and Lymphoma Affecting the Hip
Gianakos A, Patel J, Miller J, Sonnylal L, Wittig J. Metastatic Disease, Myeloma, and Lymphoma Affecting the Hip. The Journal Of Hip Surgery 2019, 03: 034-040. DOI: 10.1055/s-0039-1678743.Peer-Reviewed Original Research